Bleeding risk assessment during oral anticoagulant therapy initiation
Expert Rev Hematol
.
2012 Apr;5(2):125-7.
doi: 10.1586/ehm.12.10.
Authors
Alejandro Lazo-Langner
,
Michael J Kovacs
,
Martha Louzada
PMID:
22475279
DOI:
10.1586/ehm.12.10
No abstract available
Publication types
Editorial
MeSH terms
Administration, Oral
Anticoagulants / therapeutic use*
Atrial Fibrillation
Hemorrhage*
Humans
Risk Assessment
Venous Thromboembolism / drug therapy
Substances
Anticoagulants